KEEP Labs

Overview

KEEP Labs is a patient-intelligence and in-home medication-adherence platform for specialty therapy support programs. Its KARE by KEEP model combines patient voice, device-based medication behavior signal, and intervention routing so brands and support partners can see adherence and lived-experience issues earlier.

Engagement & Adherence Capability Model

The framework below standardizes how Rx Almanac evaluates patient-engagement-adherence capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, KEEP Labs is evaluated as patient-intelligence and in-home medication-adherence platform for specialty therapy support programs.

Capability	Buyer should compare	KEEP Labs readout
Behavioral segmentation and journey design	Patient segmentation, barrier identification, journey mapping, personalization rules, and intervention timing.	Core differentiator. Device-based signal separates KEEP from message-only adherence vendors. Validate in RFP. Confirm de-identification, consent, and manufacturer reporting.
Omnichannel patient communications	SMS, email, web, app, phone, print, and caregiver / HCP communications with consent management.	Focused overlay. KEEP centers on in-home medication behavior signal and patient voice.
Adherence coaching and persistence analytics	Refill reminders, adherence risk scoring, persistence tracking, motivational support, and outcomes measurement.	Core. KARE by KEEP is positioned around adherence and lived-experience insights.
Care-team escalation and human support	Nurse, coach, call-center, or case-manager escalation when digital nudges are insufficient.	Not the main buying reason for KEEP Labs; validate only if the SOW includes care-team escalation and human support.
Education content and program measurement	Disease education, onboarding content, MLR-ready materials, survey instruments, and performance reporting.	Adjacent. KEEP is strongest as signal capture; education workflows need scope confirmation.
Hub, pharmacy, and CRM integration	Data exchange with hubs, specialty pharmacies, CRM, EHR, claims, and manufacturer reporting environments.	Partner-dependent. Validate handoffs with PANTHERx, Auxita, McKesson Canada, or other partners.

• KARE platform: KARE by KEEP packages patient intelligence for PSP and brand teams.
• Specialty-therapy partnerships: PANTHERx, Auxita, and McKesson Canada references support the specialty-therapy lane.
• Patient voice orientation: The platform emphasizes consented lived-experience signals rather than claims-only analytics.

Buyer Fit

KEEP fits programs where real-world patient behavior, dosing confidence, home routines, or specialty therapy persistence are commercially important. It is an overlay to a hub, specialty pharmacy, PSP, or brand team rather than a substitute for dispensing or reimbursement operations.

Differentiators

• In-home signal: KEEP can capture medication behavior where hub and pharmacy systems usually lose visibility.

RFP Questions

• Which program partner owns patient consent, onboarding, device support, and opt-outs?
• What patient-level signal can be shared with the manufacturer, and how is it de-identified or governed?
• How are adverse events, product complaints, and urgent clinical issues escalated?
• What proof exists for adherence lift, intervention timing, patient satisfaction, and device reliability?

Recent Activity

• 2023: TechCrunch covered KEEP Labs’ smart storage and medication-management model.
• 2023: KEEP announced partnerships with Auxita and McKesson Canada around specialty therapy and patient-support workflows.
• 2022: KEEP and PANTHERx Rare announced a partnership focused on specialty therapy experience in the home.